Addus (ADUS, Financial) reported first-quarter revenue of $337.7 million, slightly below market expectations of $339.92 million. Despite missing revenue forecasts, the company demonstrated a strong beginning to 2025, with a 20.3% increase in revenue compared to the previous year. Additionally, adjusted EBITDA saw a significant rise of 25.1% from the same period last year.
These positive results highlight robust organic growth and include the impact of the personal care segment of Gentiva, which was fully integrated during the quarter after its acquisition on December 2, 2024. Addus continues to experience strong demand for its home-based care services, contributing to this successful quarter.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 9 analysts, the average target price for Addus HomeCare Corp (ADUS, Financial) is $141.56 with a high estimate of $160.00 and a low estimate of $120.00. The average target implies an upside of 35.63% from the current price of $104.37. More detailed estimate data can be found on the Addus HomeCare Corp (ADUS) Forecast page.
Based on the consensus recommendation from 11 brokerage firms, Addus HomeCare Corp's (ADUS, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.